𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of interferon therapy on bile duct inflammation in hepatitis C

✍ Scribed by B. F. Banner; C. Allan; L. Savas; H. L. Bonkovsky; L. Smith


Publisher
Springer
Year
1996
Tongue
English
Weight
1016 KB
Volume
428-428
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

✦ Synopsis


Inflammation of the bile ducts was studied in liver biopsies from patients with chronic hepatitis C to determine whether the frequency of inflamed bile ducts changes with therapy and correlates with other histological variables and expression of class I and II MHC antigens on ductal epithelium. Twenty patients treated at UMMC between 1991 and 1994 underwent needle biopsies of the liver before and after therapy with interferon alpha 2B (IFN). A complete response to therapy was defined as a return to normal serum alanine aminotransferase levels occurring and persisting during therapy. The number of inflamed bile ducts/total ducts (%IBDs), presence of piecemeal necrosis and lymphoid aggregates, and grade of inflammation were assessed in each high-power field in all areas with bile ducts. The frequencies of these variables were compared in cirrhotics and non-cirrhotics and in patients with complete or incomplete responses to IFN. Frozen sections of biopsies from 5 patients were immunostained using antibodies to HLA-DR and B-2 microglobulin, and positive staining was noted on bile ducts. Before therapy, the %IBD was slightly greater in patients with cirrhosis. After IFN, both %IBD and serum alkaline phosphatase levels decreased in non-cirrhotics who responded to IFN. The change in frequency of IBD with IFN paralleled the changes in the other histological features. No correlation was noted between bile duct inflammation and expression of class I and II antigens. The conclusion is that inflammation of the bile ducts occurs frequently in chronic hepatitis C, correlates with other features of inflammation in the triads, and decreases in response to IFN therapy.


πŸ“œ SIMILAR VOLUMES


GBV-C/HGV infection in chronic hepatitis
✍ Oshita, Masahide; Hayashi, Norio; Mita, Eiji; Iio, Sadaharu; Hiramatsu, Naoki; H πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 2 views

A novel virus (GBV-C/HGV) may be associated with some liver diseases including fulminant hepatitis and acute and chronic hepatitis. On the other hand, many investigations showed that this infection does not contribute to liver disease. GBV-C/HGV has been found to occur in association with infection

Efficacy of interferon alfa therapy in c
✍ Gotaro Yamada; Masahiro Takatani; Fumitoshi Kishi; Michiko Takahashi; Toshihiko πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 557 KB

TAKA0 TSUJI,~ SADAHITO SHIN,2 MASASHI TA"03, MICKEY s. URDEA,4 AND JANICE A. KOLBERG4 To clarify the viral factors that may predict the therapeutic effect of interferon (IFN) in chronic hepatitis C (CHC) patients, we investigated the quantitative serum hepatitis C virus (HCV) RNA level, genotype, a

Effect of interferon administration on s
✍ Kazuaki Chayama; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Toyomi Matsumoto; Yo πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 412 KB πŸ‘ 2 views

Hepatitis C virus RNA as detected by reverse transcription and nested polymerase chain reaction was monitored in 16 patients with chronic hepatitis C treated with interferon. Hepatitis C virus R N A became undetectable after 4 to 8 wk of interferon administration in 13 of the 16 patients. During 6 m

Effect of propranolol on hepatic and sys
✍ Bernard Willems; Jean-Pierre Villeneuve; Dr. P.-Michel Huet πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 638 KB

Propranolol has been reported to reduce portal and wedged hepatic vein pressures in man and may be useful for the prevention of variceal bleeding. However, its mechanism of action remains unclear. We have examined the effect of propranolol on the systemic and hepatic circulations in dogs with chroni